The life-course impact of smoking on hypertension, myocardial infarction and respiratory diseases

Sci Rep. 2017 Jun 28;7(1):4330. doi: 10.1038/s41598-017-04552-5.

Abstract

The objective of this study was to examine the impact of smoking on respiratory diseases, hypertension and myocardial infarction, with a particular focus from a life-course perspective. In this study, 28,577 males from a Chinese longitudinal survey were analysed. The effects of smoking on the risk of respiratory diseases, hypertension and myocardial infarction were assessed from a life-course perspective and a current view separately. No significant associations were found between smoking and the risk of incident respiratory diseases, hypertension and myocardial infarction in the group younger than 35. Among study participants aged between 36-55 and 56-80, smoking was positively associated with the risk of incident respiratory diseases, hypertension and myocardial infarction from the life-course perspective, and the risk increased with age. In contrast, the results from a current view showed inverse associations between smoking and the risk of the diseases mentioned above. Our findings highlight that it is essential to quantify the effects of smoking from a life-course perspective in future research and to suggest that smokers quit smoking as soon as possible, regardless of the temporary side effects of quitting.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Algorithms
  • Female
  • Health Impact Assessment
  • Humans
  • Hypertension / epidemiology*
  • Hypertension / etiology*
  • Male
  • Middle Aged
  • Models, Statistical
  • Myocardial Infarction / epidemiology*
  • Myocardial Infarction / etiology*
  • Odds Ratio
  • Public Health Surveillance
  • Respiration Disorders / epidemiology*
  • Respiration Disorders / etiology*
  • Smoking / adverse effects*
  • Time Factors
  • Young Adult